LAMISIL DIRECT Trademark

Trademark Overview


On Friday, May 4, 2007, a trademark application was filed for LAMISIL DIRECT with the United States Patent and Trademark Office. The USPTO has given the LAMISIL DIRECT trademark a serial number of 77172903. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 5, 2009. This trademark is owned by Novartis AG. The LAMISIL DIRECT trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic preparations for medical and veterinary use; Pharmaceutical preparations for the treatment of and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, diabetes and metabolic diseases, for use in dermatology, in oncology, in hematology, in tissue and organ transplantation, in ophthalmology, for use in the gastroenterological area and in the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for treating bacteria-based diseases, anti-infectives, anti-bacterials, antivirals, anti-biotics, anti-fungals, vaccines
lamisil direct

General Information


Serial Number77172903
Word MarkLAMISIL DIRECT
Filing DateFriday, May 4, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 5, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 11, 2008

Trademark Statements


Goods and ServicesDiagnostic preparations for medical and veterinary use; Pharmaceutical preparations for the treatment of and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, diabetes and metabolic diseases, for use in dermatology, in oncology, in hematology, in tissue and organ transplantation, in ophthalmology, for use in the gastroenterological area and in the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for treating bacteria-based diseases, anti-infectives, anti-bacterials, antivirals, anti-biotics, anti-fungals, vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 8, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Monday, January 5, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 5, 2009ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 3, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 11, 2008PUBLISHED FOR OPPOSITION
Wednesday, February 20, 2008NOTICE OF PUBLICATION
Tuesday, February 5, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, February 5, 2008ASSIGNED TO LIE
Thursday, December 27, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 17, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 17, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 17, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 28, 2007NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 28, 2007NON-FINAL ACTION E-MAILED
Thursday, June 28, 2007NON-FINAL ACTION WRITTEN
Thursday, June 14, 2007ASSIGNED TO EXAMINER
Thursday, June 14, 2007ASSIGNED TO EXAMINER
Tuesday, May 8, 2007NEW APPLICATION ENTERED IN TRAM